Our earlier findings suggest bacterially supplemented methionine sufficient for partial rescue of proliferation, leading us to investigate the expression levels of a known methionine transporter, LAT1 (SLC7A5) in tumor and NM tissue samples. Here, SLC7A5 is linked to nemaline myopathy.